Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 4Q Financial Reports: Millipore | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

4Q Financial Reports: Millipore

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Millipore

4Q Revenues: $256.3 million (+14%)

4Q Earnings: $1 million* (income was $24.8 million in 4Q2004)

YTD Revenues: $991 million (+12%)

YTD Earnings: $80.2 million (-24%)

Comments: In constant currency, quarterly revenue growth was 19%, led by 24% growth from the company’s Bioprocess division and 11% growth from its Bioscience division. Full year performance was led by 15% growth in the Bioprocess division and 7% growth in the Bioscience division.

*Includes a one-time tax expense of $30.6 million for the repatriation of foreign earnings and a tax benefit of $3.4 million from the reversal of tax valuation allowances. Fourth quarter results also included expenses of approximately $8.4 million relating to the company’s manufacturing consolidation strategy, amortization of acquired intangibles, and professional fees associated with the repatriation of foreign earnings.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters